Advanced Gastric Cancer. Results Observed in a Private Regional Health Center
Main Article Content
Abstract
Gastric cancer (GC) is the fourth of oncological diseases in women and the first men. For advanced GC (AGC), surgery remains the treatment of choice, which involves performing gastrectomies and D2 lymphadenectomy. The aim of this study is to determine postoperative morbidity (POM), mortality, survival (SV) and recurrence in patients resected by AGC. Retrospective case series of patients with AGC undergoing gastrectomies and LD2, consecutively at the Clínica Mayor in Temuco, between the years 2008 and 2014. The outcome variable was SV. Other variables of interest were: POM, mortality and recurrence. Patients were followed clinically. Descriptive statistics were used, with measures of central tendency and dispersion. Twenty-two patients (68.2 % male) were operated, with a median age of 61 years. The most frequent location was subcardial (45.5 %); the most common type of resection was total gastrectomy (54.5 %). The medium surgical time, resection of lymph nodes, and hospital stay were 155 min, 24 and 6 days respectively. POM was 18.2 %. With a median follow up of 22.5 months, a global actuarial SV was verified to 5 years 37 %, and recurrence of 36.4 %. The results achieved, in terms of POM, mortality and SV series are comparable to national and international centers.
References
Alici, S.; Kaya, S.; Izmirli, M.; Tuncer, I.; Dogan, E.; Ozbek, H. & Sayarlioglu, H. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma. Med. Sci. Monit., 12(5):CR221- 9, 2006.
Al-Moundhri, M. S.; Al-Bahrani, B.; Burney, I. A.; Nirmala, V.; Al-Madhani, A.; Al-Mawaly, K.; AlNabhani, M.; Thomas, V.; Ganguly, S. S. & Grant, C. S. The prognostic determinants of gastric cancer treatment outcome in Omani Arab patients. Oncology, 70(2):90-6, 2006. Butte, J. M.; Duarte, I.; Crovari, F.; Guzmán, S. &
Llanos, O. Gastric cancer in patients older than 75 years. Surgical treatment and long-term survival. Cir. Esp., 82(6):341-5, 2007.
Calderón, G. M. E.; Csendes, J. A.; Ospina, P. C.; Lara, S. A. & Hodgson, O. F. Evolución del cáncer gástrico en 30 años 1975-2005. Rev. Chil. Cir., 59(5):366-9, 2007.
Clavien, P. A.; Barkun, J.; de Oliveira, M. L.; Vauthey, J. N.; Dindo, D.; Schulick, R. D.; de Santibañes, E.; Pekolj, J.; Slankamenac, K.; Bassi, C.; Graf, R.; Vonlanthen, R.; Padbury, R.; Cameron, J. L. & Makuuchi, M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann. Surg., 250(2):187-96, 2009.
Cornejo, C. & Portanova, M. Estudio Comparativo de Disección Ganglionar D1 y D2 para el Cáncer Gástrico Avanzado en el Hospital Rebagliati. Rev. Gastroenterol. Perú, 26(4):351-6, 2006.
Díaz de Liaño, A.; Yárnoz, C.; Aguilar R, Artieda, C. & Ortiz, H. Morbidity and mortality in gastrectomy with D2 lymphadenectomy in a specialised unit. Cir. Esp., 83(1):18-23, 2008.
Díaz de Liaño, A.; Yárnoz, C.; Artieda, C.; Aguilar, R.;Artieda, C.; Viana, S.; Artajona, A. & Ortiz, H. Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer. Clin. Transl. Oncol., 11(3):178-82, 2009.
García-Jirón, C.; Lastra Aras, E. & Hernández García, R. Tratamiento del carcinoma diseminado de estómago: ¿pauta estándar? Oncología (Barc.), 27(4):47-50, 2004.
Garrido, M.; Melgoza, G.; Galindo, H.; Madrid, J.; Sánchez, C.; Nervi, B.; Alvarez, M. & Orellana, E. Nuevas alternativas en el tratamiento del cancer gástrico avanzado. Rev. Med. Chile, 135:1380-7, 2007.
Itriago, G. L.; Silva, I. N. & Cortés, F. G. Cáncer en Chile y el mundo: una mirada epidemiológica, presente y futuro. Rev. Med. Clin. Las Condes, 24:531- 52, 2013.
Lima, E. M.; Leal, M. F.; Motta, F. J. N.; Assumpção, P. P.; Harada, M. L.; Smith, M. A. C.; Burbano, R. R. & Casartelli, C. Study of methylation pattern of de novo DNA methyltransferase genes and its correlation with DNA methylation pattern of RUNX3 in individuals with gastric cancer from Northern Region of Brazil. Int. J. Morphol, 25(4):817-24, 2007.
Macdonald, J. S.; Smalley, S. R.; Benedetti, J.; Hundahl, S. A.; Estes, N. C.; Stemmermann, G. N.; Haller, D. G.; Ajani, J. A.; Gunderson, L. L.; Jessup, J. M. & Martenson, J. A. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N. Engl. J. Med., 345(10):725-30, 2001.
Manterola, C.; Torres, R.; Burgos, L.; Vial, M.; Pineda, V. & Grupo MINCIR. Calidad metodológica de un artículo de tratamiento de cáncer gástrico adoptado como protocolo por algunos hospitales chilenos. Rev. Med. Chile, 134:920-6, 2006.
Manterola, C. & Astudillo, P. Checklist for Reporting of Descriptive Observational Studies. MINCIR Initiative. Int. J. Morphol., 31(1):115-20, 2013.
Ministerio de Salud (MINSAL). Informe final: Estudio de carga enfermedad y carga atribuible. Santiago de Chile, Gobierno de Chile, 2008.
Ministerio de Salud (MINSAL). Primer informe de registros poblacionales de cáncer en Chile quinquenio 2003-2007. Santiago de Chile, Gobierno de Chile, 2012. Disponible en: http://deis.minsal.cl/ev/mortalidad_causas/cancer_estomago/series/consulta.asp.Porta, M. S. A Dictionary of Epidemiology. 6th ed. NewYork, Oxford University Press, 2014.
Roco, A.; Quiñones, L.; Acevedo, C. & Zagmutt, O. Cancer status in Chile 2000-2010. Cuad. Méd. Soc. (Santiago de Chile), 53(2):83-94, 2013.
Ruiz, E.; Sánchez, J.; Celis, J.; Payet, E.; Berrospi, F.; Chavez, I. & Young, F. Surgical outcome of 801 patients with localized gastric cancer treated with d2 lymphadenectomy. Rev. Gastroenterol. Peru., 29(2):124-31, 2009.
Tapia, E. O.; Roa, S. J. C.; Manterola, D. C.; Villaseca, H. M.; Gutiérrez, M. V.; Flores, O. P.; Araya, O. J. C. & Guzmán, G. P. Cáncer gástrico en una región de Chile: Comparación de variables clínicas y morfológicas en dos períodos (1986-1995 y 1996- 2005). Rev. Chil. Cir., 62(2):125-30, 2010.
Tapia, E. O.; Roa, S. J. C.; Manterola, D. C.; Puga, A. V.; Villaseca, H. M. & Araya, O. J. C. Factores asociados al pronóstico de pacientes operados por cáncer gástrico avanzado. Rev. Chil. Cir., 63(2):154- 61, 2011.
Salomon, J. A. Nuevos pesos de la discapacidad para la carga mundial de morbilidad. Boletín de la Organización Mundial de la Salud, 88:879-879, 2010. Disponible en: http://www.who.int/bulletin/ volumes/88/12/10-084301/es
Sastre, J.; García-Saenz, J. A. & Díaz-Rubio, E. Chemotherapy for gastric cancer. World J. Gastroenterol., 12(2):204-13, 2006.
Stewart, B. W. & Kleihues, P. (Eds.). World Cancer Report. Lyon, IARC Press, 2003. pp.35.
Valenti, V.; Hernandez-Lizoaín, J. L.; Beorlegui, M. C.; Diaz-Gozalez, J. A.; Regueira, F. M.; Rodriguez, J. J.; Viudez, A.; Sola, I. & Cienfuegos, J. A. Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy. J. Surg. Oncol., 104(2):124-9, 2011.
World Health Organization (WHO). The Global Burden of Disease. Geneva, WHO Press, 2004. pp.8-26.